Assessment of Minimal Hepatic Encephalopathy (with Emphasis on Computerized Psychometric Tests)

Clinics in Liver Disease

Volumn 16, Issue 1, 2012, Pages 43-55

  Kappus, Matthew R ^a   Bajaj, Jasmohan S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cognition; Cognitive drug research system; Computerized testing; Critical flicker frequency; Diagnosis; Inhibitory control test; Minimal hepatic encephalopathy

Indexed keywords

ALERTNESS; ATTENTION; CLINICAL ASSESSMENT; CLOCK DRAWING TEST; COGNITIVE DEFECT; COGNITIVE DRUG RESEARCH COMPUTERIZED ASSESSMENT SYSTEM; COMPUTER ANALYSIS; DECISION MAKING; DIAGNOSTIC TEST; DIGIT SYMBOL TEST; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EXECUTIVE FUNCTION; FUNCTIONAL STATUS; HEALTH CARE COST; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HUMAN; IMPACT ASSESSMENT SYSTEM; INHIBITION (PSYCHOLOGY); INHIBITORY CONTROL TEST; LIVER CIRRHOSIS; MENTAL HEALTH; MOTOR VEHICLE; NEUROLOGIC DISEASE; PATIENT CARE; PLANNING; PROBLEM SOLVING; PSYCHOMETRY; QUALITY OF LIFE; REACTION TIME; RESOURCE MANAGEMENT; RESPONSE TIME; REVIEW; SPECTRUM OF NEUROCOGNITIVE IMPAIRMENT IN CIRRHOSIS; STERNBERG PARADIGM; STERNBERG SCAN TASK; WORKING MEMORY;

HEPATIC ENCEPHALOPATHY; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 84856604118     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2011.12.002     Document Type: Review

References (52)

1. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
2. Poordad F.F. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007, 25(Suppl 1):3-9.
3. Bajaj J.S., Wade J.B., Sanyal A.J. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 2009, 50:2014-2021.
4. Bajaj J.S., Hafeezullah M., Franco J., et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008, 135:1591-1600.e1.
5. Weissenborn K., Ennen J.C., Schomerus H., et al. Neuropsychological characterization of hepatic encephalopathy. JHepatol 2001, 34:768-773.
6. Ford J.M., Gray M., Whitfield S.L., et al. Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 2004, 61:119-129.
7. Schiff S., Vallesi A., Mapelli D., et al. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis 2005, 20:381-392.
8. Ortiz M., Jacas C., Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. JHepatol 2005, 42(Suppl):S45-S53.
9. Saxena N., Bhatia M., Joshi Y.K., et al. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002, 22:190-197.
10. Vergara-Gomez M., Flavia-Olivella M., Gil-Prades, et al. Diagnosis and treatment of hepatic encephalopathy in Spain: results of a survey of hepatologists. Gastroenterol Hepatol 2006, 29:1-6.
11. Bajaj J.S., Etemadian A., Hafeezullah M., et al. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology 2007, 45:833-834.
12. Amodio P., Schiff S., Del Piccolo F., et al. Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing. Metab Brain Dis 2005, 20:115-127.
13. Bajaj J.S. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008, 14:3609-3615.
14. Bajaj J.S., Hafeezullah M., Hoffmann R.G., et al. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007, 102:1903-1909.
15. Bajaj J.S., Hafeezullah M., Hoffmann R.G., et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008, 47:596-604.
16. Bajaj J.S., Saeian K., Schubert C.M., et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 2009, 50:1175-1183.
17. Ortiz M., Córdoba J., Doval E., et al. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther 2007, 26(6):859-867.
18. Amodio P., Campagna F., Olianas S., et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. JHepatol 2008, 49:346-353.
19. Romero-Gomez M., Córdoba J., Jover R., et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007, 45:879-885.
20. Riggio O., Ridola L., Pasquale C., et al. Asimplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol 2011, 9:613-616.e1.
21. Sotil E.U., Gottstein J., Ayala E., et al. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl 2009, 15:184-192.
22. Sorrell J.H., Zolnikov B.J., Sharma A., et al. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci 2006, 60:174-181.
23. Meyer T., Eshelman A., Abouljoud M. Neuropsychological changes in a large sample of liver transplant candidates. Transplant Proc 2006, 38:3559-3560.
24. Douglass A., Al Mardini H., Record C. Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy. JHepatol 2001, 34:658-664.
25. Oppong K.N., Al-Mardini H., Thick M., et al. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study. Hepatology 1997, 26:870-876.
26. Rees C.J., Oppong K., Al Mardini H., et al. Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut 2000, 47:571-574.
27. Amodio P., Del Piccolo F., Marchetti P., et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999, 29:1662-1667.
28. Garavan H., Ross T.J., Stein E.A. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci USA 1999, 96:8301-8306.
29. Konrad K., Gauggel S., Manz A., et al. Inhibitory control in children with traumatic brain injury (TBI) and children with attention deficit/hyperactivity disorder (ADHD). Brain Inj 2000, 14:859-875.
30. Pliszka S.R., Liotti M., Woldorff M.G. Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 2000, 48:238-246.
31. Ballard J.C. Assessing attention: comparison of response-inhibition and traditional continuous performance tests. JClin Exp Neuropsychol 2001, 23:331-350.
32. Walker A.J., Shores E.A., Trollor J.N., et al. Neuropsychological functioning of adults with attention deficit hyperactivity disorder. JClin Exp Neuropsychol 2000, 22:115-124.
33. Bajaj J.S., Saeian K., Verber M.D., et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007, 102:754-760.
34. Bajaj J.S., Heuman D.M., Wade J.B., et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011, 140:478-487.e1.
35. Amodio P., Ridola L., Schiff S., et al. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 2010, 139:510-518. 518.e1-2.
36. Mardini H., Saxby B.K., Record C.O. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology 2008, 135:1582-1590.
37. McKeith I., Del Ser T., Spano P., et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000, 356:2031-2036.
38. Forton D.M., Thomas H.C., Murphy C.A., et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002, 35:433-439.
39. Wesnes K.A., McKeith I.G., Ferrara R., et al. Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 2002, 13:183-192.
40. Tsushima M., Tsushima W., Tsushima V., et al. Acase control study of ImPACT: a brief and effective web-based neuropsychological assessment battery to diagnose minimal hepatic encephalopathy (MHE) [Abstract]. JHepatol 2010, 52(Suppl 1):S87.
41. Parsons-Smith B.G., Summerskill W.H., Dawson A.M., et al. The electroencephalograph in liver disease. Lancet 1957, 273:867-871.
42. Quero J.C., Hartmann I.J., Meulstee J., et al. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996, 24:556-560.
43. Van der Rijt C.C., Schalm S.W., De Groot G.H., et al. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr Clin Neurophysiol 1984, 57:423-426.
44. Montagnese S., Jackson C., Morgan M.Y. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. JHepatol 2007, 46:447-458.
45. Marchetti P., D'Avanzo C., Orsato R., et al. Electroencephalography alterations in patients with cirrhosis. Gastroenterology 2011, 141:1680-1689.
46. Amodio P., Del Piccolo F., Pettenò E., et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. JHepatol 2001, 35:37-45.
47. Montagnese S., Amodio P., Morgan M.Y. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis 2004, 19:281-312.
48. Kircheis G., Wettstein M., Timmermann L., et al. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002, 35:357-366.
49. Haussinger D., Kircheis G., Fischer R., et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?. JHepatol 2000, 32:1035-1038.
50. Eckstein A.K., Reichenbach A., Jacobi P., et al. Hepatic retinopathia. Changes in retinal function. Vision Res 1997, 37:1699-1706.
51. Reichenbach A., Fuchs U., Kasper M., et al. Hepatic retinopathy: morphological features of retinal glial (Muller) cells accompanying hepatic failure. Acta Neuropathol 1995, 90:273-281.
52. Sharma P., Sharma B.C., Puri V., et al. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. JHepatol 2007, 47:67-73.